NanoGroup S.A.’s acquisition of bridge financing.
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of
2024-03-25
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of
March 25, 2024. Members of the Board received a notice from Mr. Michał Lach pursuant to Art. 69 para. 1 of the Act on Public
In January 2024, the first publication from the Polepi project was released.“Nanoparticle-Encapsulated Epirubicin Efficacy in the Inhibition of Growth of Orthotopic Ovarian Patient-Derived Xenograft in
In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study conducted in
The conducted pig liver perfusion is another step taken by the company to introduce an innovative organ perfusion system to the Polish market. NanoGroup’s first
“NanoGroup is my child, whom I was with when it was born, to whom I gave my whole heart throughout all the years of its
Bringing at least one project to partnership by the end of 2024, having at least 5 projects in the portfolio by the end of the
The Supervisory Board of NanoGroup S.A. has approved the Company’s new Development Strategy for 2023-2025.
Today on Fakty TVN, Prof. Dr. Katherine H. K., a professor of transplantation, spoke about our research, the record time for keeping a kidney out
Prof. NanoGroup S.A. talks about the future of transplantation, the possibilities that the technology being developed by NanoGroup S.A. opens up for the field, and
Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.
Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.